Daniel Schwartzlose

Private Equity Investor at

NC Advisory A/S

Consumer Services

Health Technology

Finance

Profile

Daniel Schwartzlose is currently Managing Director at NC Advisory A since 2022.
Mr. Schwartzlose was President & Xellia International at Xellia Pharmaceuticals AS from 2019 to 2022 and worked at Xellia Pharmaceuticals AS from 2014 to 2022.
Mr. Schwartzlose earned an MBA from the University of Technology Sydney in 2002 and graduated from the University of Copenhagen in 2003.

Daniel Schwartzlose active positions

Companies	Position	Start
NC Advisory A/S NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager	Private Equity Investor	2021-12-31

All active positions of Daniel Schwartzlose

Former positions of Daniel Schwartzlose

Companies	Position	End
Xellia Pharmaceuticals AS Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs	Private Equity Investor	2021-12-31

See the detail of Daniel Schwartzlose's experience

Training of Daniel Schwartzlose

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Schwartzlose's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
University of Technology Sydney University of Technology Sydney Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xellia Pharmaceuticals AS Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical drugs	Health Technology
NC Advisory A/S NC Advisory A/S Investment ManagersFinance Functions as an alternative investment manager	Finance